AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimepye M 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Bluepipes Healthcare Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimepye M 2mg/500mg Tablet ER

Glimepiride/Metformin extended-release tablets (2mg/500mg) are classified as antidiabetic agents. This dual-medication formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled glucose levels; abrupt cessation can elevate blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight control as directed by your healthcare provider. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; learn to identify symptoms like sweating, dizziness, headache, and trembling, and have readily available glucose (e.g., sugary snacks, fruit juice). Alcohol consumption should be minimized due to its hypoglycemic effect. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor prior to use if pregnant or breastfeeding. Regular blood glucose monitoring, along with periodic blood cell and liver function tests, are recommended.

Primary Ingredients of Glimepye M 2mg/500mg Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Glimepye M 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimepye M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. The Glimepye M 2mg/500mg Extended-Release tablet should be administered with a meal.

Common Side effects of Glimepye M 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimepye M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimepye M 2mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Glimepye M 2mg/500mg Tablet ER works:

Glimepye M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Glimepye M 2mg/500mg Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimepyride/Metformin 2mg/500mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimepyride/Metformin 2mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimepye M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Glimepye M 2mg/500mg Extended-Release tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimepye M 2mg/500mg Extended-Release tablets cautiously, as dose modification may be necessary. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimepye M 2mg/500mg Tablet ER :

Should you forget to take a Glimepye M 2mg/500mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimepye M 2mg/500mg Tablet ER

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimepye M 2mg/500mg Tablet ER

Maintain this medication within its original, sealed container. Follow the storage guidelines specified on the packaging. Discard any remaining medicine. Prevent access by children, pets, and others.
Glimepye M 2mg/500mg Tablet ER carries a risk of lactic acidosis, a serious, potentially life-threatening condition resulting from excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare adverse effect is particularly concerning for individuals with impaired kidney function, the elderly, or those who consume significant amounts of alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow pulse. Should these symptoms appear, discontinue Glimepye M 2mg/500mg Tablet ER use and seek immediate medical attention.
Glimepyride and Metformin, combined as Glimepye M 2mg/500mg Extended-Release tablets, manage type 2 diabetes mellitus in adults. This dual therapy enhances blood sugar control when coupled with a healthy diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin acts by decreasing hepatic glucose production and increasing insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes mellitus.
Glimepye M 2mg/500mg Extended-Release Tablets may cause common adverse reactions including low blood sugar, taste disturbances, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially severe side effects such as lactic acidosis are also possible. Prolonged therapy may result in vitamin B12 deficiency.
Prolonged Glimepyride/Metformin 2mg/500mg extended-release tablet use can lead to Vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications including peripheral neuropathy (manifested as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and gait instability. Preventive measures proposed by some studies involve supplemental Vitamin B12 intake annually.
Indeed, Glimepye M 2mg/500mg Extended-Release Tablets can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimepye M 2mg/500mg Extended-Release tablets and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimepye M 2mg/500mg Tabl...
44
MRP 53
16% off